🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Sreepriya Prasannan

Sreepriya Prasannan

Life Science Journalist & Editor

Sreepriya Prasannan is the Founder and Lead Editor of Priya Life Science. With a deep passion for the Irish pharmaceutical and MedTech sectors, she specializes in sharing actionable career insights, digital regulatory trends, and GMP compliance strategies.

191
Articles
7
Topics
1219
Min Published
Filter: All 191 Industry 75 Regulatory Affairs 42 Pharmaceutical 25 Biotechnology 16 MedTech 16 LinkedIn 12 Clinical Trials 5

All Articles

Page 4 of 16 — 191 articles
GEODIS Expands Pharmaceutical Logistics in Poland: Securing Dual GDP and IATA CEIV Pharma Certifications
Regulatory Affairs
GEODIS Expands Pharmaceutical Logistics in Poland: Securing Dual GDP and IATA CEIV Pharma Certifications
GEODIS has renewed its IATA CEIV Pharma accreditation in Warsaw and secured GDP certification for its Stryków Dobra contract logistics facility. This dual compliance milestone bolsters Poland’s status as a critical gateway in Europe’s pharmaceutical supply chain.
16 Jul 2026 10 min
Normalization or Correction? Ireland’s Goods Exports Drop 29% in May as Pharma Surplus Narrows
Biotechnology
Normalization or Correction? Ireland’s Goods Exports Drop 29% in May as Pharma Surplus Narrows
Ireland’s goods exports fell by 29.1% to €16.5 billion in May 2026, driven by a €8 billion drop in pharmaceutical shipments, while imports rose 17.5% to €13.1 billion, narrowing the trade surplus.
15 Jul 2026 3 min
Pilot Photonics Secures €10.4 Million EIC Accelerator Funding to Scale Deeptech Photonic Chips
Biotechnology
Pilot Photonics Secures €10.4 Million EIC Accelerator Funding to Scale Deeptech Photonic Chips
Dublin-based Pilot Photonics receives up to €10.4 million in EIC Accelerator funding to scale high-volume manufacturing of its patented photonic integrated circuits (PICs) for AI data centres, satellite transceivers, and 6G networks.
15 Jul 2026 3 min
Intel Announces €5 Billion ($5.7 Billion) AI-Driven Semiconductor Expansion at Leixlip, Kildare
Industry
Intel Announces €5 Billion ($5.7 Billion) AI-Driven Semiconductor Expansion at Leixlip, Kildare
Intel has announced a massive €5 billion ($5.7 billion) capital investment at its Leixlip campus in Ireland to expand semiconductor manufacturing capacity, driven by global demand for AI and high-performance computing.
14 Jul 2026 6 min
MGS Mfg. Group Scales Up European Healthcare Manufacturing with 115,000 Sq Ft Leixlip Hub
Biotechnology
MGS Mfg. Group Scales Up European Healthcare Manufacturing with 115,000 Sq Ft Leixlip Hub
MGS Mfg. Group completes a major 115,000 sq ft expansion of its Leixlip, Ireland facility, boosting ISO Class 7 and 8 cleanroom capacity, advanced automation, and controlled "whiteroom" environments to meet surging European medical device and pharmaceutical demands.
14 Jul 2026 5 min
Irish EU Council Presidency Prioritizes €10B Biotech Act to Revitalize European Clinical Trials and Sovereign Biomanufacturing
Regulatory Affairs
Irish EU Council Presidency Prioritizes €10B Biotech Act to Revitalize European Clinical Trials and Sovereign Biomanufacturing
Irish Health Minister Jennifer Carroll MacNeill positions the €10 billion EU Biotech Act as a key priority for Ireland's Council Presidency, aiming to reverse the decline in clinical trials while balancing pharmaceutical incentives against patient access to affordable therapies.
14 Jul 2026 5 min
Addressing the 801-Day Lag: Ireland’s Drug Approval System Demands Urgent Structural Reform
Regulatory Affairs
Addressing the 801-Day Lag: Ireland’s Drug Approval System Demands Urgent Structural Reform
The latest EFPIA Patients W.A.I.T. Indicator report reveals that Irish patients wait an average of 801 days to access newly approved medicines, prompting calls for an overhaul of the HSE and NCPE reimbursement processes and a dedicated mechanism for rare disease orphan drugs.
14 Jul 2026 5 min
Beyond Google: Why B2B Pharma is Adopting 'Search Everywhere' and Generative Engine Optimization (GEO) in 2026
Industry
Beyond Google: Why B2B Pharma is Adopting 'Search Everywhere' and Generative Engine Optimization (GEO) in 2026
As professional buyers shift from search engines to AI assistants and LinkedIn for vendor research, B2B pharmaceutical and life science companies are pivoting from traditional keyword rankings to "Search Everywhere" and Generative Engine Optimization (GEO).
09 Jul 2026 5 min
University of Galway to Lead New €64.5m Research Ireland Rinn Medical Devices Centre
Industry
University of Galway to Lead New €64.5m Research Ireland Rinn Medical Devices Centre
The University of Galway has been chosen to lead the new €64.5 million Research Ireland Rinn Medical Devices Centre as part of a landmark €460 million government investment in seven new national Rinn research centres.
09 Jul 2026 5 min
Chanelle Pharma Renews Historic Partnership with Galway Races Summer Festival 2026
Industry
Chanelle Pharma Renews Historic Partnership with Galway Races Summer Festival 2026
Chanelle Pharma has confirmed the renewal of its long-standing partnership with the Galway Races Summer Festival for 2026, marking 41 consecutive years of sponsoring the prestigious Leading Trainer Award alongside the Best Turned Out Series.
09 Jul 2026 4 min
The Distortion of Irish GDP: How 'Phantom Exports' Are Reshaping the Biopharma Landscape
Industry
The Distortion of Irish GDP: How 'Phantom Exports' Are Reshaping the Biopharma Landscape
Ireland's contract manufacturing exports-colloquially known as "phantom exports"-are surging once again, raising fresh questions about the decoupling of headline economic figures from the domestic life sciences economy.
09 Jul 2026 5 min
The Anatomy of a Biologics Warning Letter: Deconstructing Genzyme Waterford’s FDA Audit
Pharmaceutical
The Anatomy of a Biologics Warning Letter: Deconstructing Genzyme Waterford’s FDA Audit
The FDA CBER warning letter issued to Genzyme Ireland’s Waterford site in June 2026 is a watershed moment for Irish biopharma. From 11x repeated filter tests to discarded checklists and unexplained deviation cancellations, we analyze the specific CGMP violations and detail what this compliance failure means for quality management across the sector.
08 Jul 2026 9 min